SNOA vs UDR · rev $19.5M vs P/E 26, rev $1.71B
Sonoma Pharmaceuticals Inc (SNOA) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
SNOA currently screens at market cap $4.9M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the SNOA and UDR stock pages for the full models.
Not investment advice.